Growth in this market is mainly driven by factors such as rising incidence of cardiovascular disorders, growing use of mobile cardiac telemetry, and rise in private institutional nursing and home care.
This report segments the CM & CRM devices market on the basis of product type, end user, and region. On basis of product, cardiac monitoring devices market is categorized into ECG devices, implantable loop recorder (ILR), cardiac output monitoring (COM), and event monitors. The ECG devices segment is expected to account for the largest share during the forecast period due to the rapid technological advancements in the improvement of ECG devices.
On the basis of product, the cardiac rhythm management devices market is categorized into defibrillators, pacemakers, and cardiac resynchronization therapy (CRT) devices. The defibrillators segment is expected to hold a major share of the market during the forecast period due to the wide usage of defibrillators for cardiovascular patients.
New product launches and approvals were the key strategies adopted by major industry players to increase their market share and cater to unmet needs of the customers. Emerging and immature markets such as the Brazil, Japan, China, and India are lucrative for CM & CRM devices.
Biotronik SE & Co., Kg
Boston Scientific Corporation
Cardiac Science Corporation
Mortara Instrument, Inc.
St. Jude Medical, Inc.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cardiac Monitoring Devices Market, by Product
7 CRM Devices Market, by Product
8 Cardiac Monitoring and Cardiac Rhythm Management Devices Market, by End User
9 Cardiac Monitoring and Cardiac Rhythm Management Market, by Region